{"text": "The use of the methylation status of P16, RASSF1A, APC, RAR\u03b2, DAPK, CDH13, and MGMT could become a promising and powerful biomarker for the detection and screening of NSCLC in blood in clinical settings. Further large-scale studies with large sample sizes are necessary to confirm our findings in the future.", "denotations": [{"id": "T1", "obj": "gene", "span": {"begin": 37, "end": 40}}, {"id": "T2", "obj": "gene", "span": {"begin": 42, "end": 49}}, {"id": "T3", "obj": "gene", "span": {"begin": 51, "end": 54}}, {"id": "T4", "obj": "gene", "span": {"begin": 56, "end": 60}}, {"id": "T5", "obj": "gene", "span": {"begin": 62, "end": 66}}, {"id": "T6", "obj": "gene", "span": {"begin": 68, "end": 73}}, {"id": "T7", "obj": "gene", "span": {"begin": 79, "end": 83}}, {"id": "T8", "obj": "disease", "span": {"begin": 167, "end": 172}}]}
